These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 13470038)

  • 1. An evaluation of the antihistaminic activity of a new series of chalcone derivatives.
    ROSSI GV; AVELLINO JD
    Am J Pharm Sci Support Public Health; 1957 Sep; 129(9):324-31. PubMed ID: 13470038
    [No Abstract]   [Full Text] [Related]  

  • 2. Design, synthesis, and docking studies of novel benzopyrone derivatives as H(1)-antihistaminic agents.
    Farag NA; Mohamed SR; Soliman GA
    Bioorg Med Chem; 2008 Oct; 16(19):9009-17. PubMed ID: 18789706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives.
    Weis R; Schweiger K; Faist J; Rajkovic E; Kungl AJ; Fabian WM; Schunack W; Seebacher W
    Bioorg Med Chem; 2008 Dec; 16(24):10326-31. PubMed ID: 18977145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological investigation of novel 4-(3-ethylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a] quinazolin-5-ones as a new class of H1-antihistaminic agents.
    Alagarsamy V; Kavitha K; Rupeshkumar M; Solomon VR; Kumar J; Kumar DS; Sharma HK
    Acta Pharm; 2009 Mar; 59(1):97-106. PubMed ID: 19304562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New potential antihistaminic compounds. Virtual combinatorial chemistry, computational screening, real synthesis, and pharmacological evaluation.
    Duart MJ; Antón-Fos GM; Alemán PA; Gay-Roig JB; González-Rosende ME; Gálvez J; García-Domenech R
    J Med Chem; 2005 Feb; 48(4):1260-4. PubMed ID: 15715494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-(3-Methoxyphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones: new class of H1-antihistaminic agents.
    Alagarsamy V; Sharma HK; Parthiban P; Singh JC; Murugan ST; Solomon VR
    Pharmazie; 2009 Jan; 64(1):5-9. PubMed ID: 19216223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a new antihistaminic drug.
    SCHAFFER N
    Ann Allergy; 1957; 15(4):427-8. PubMed ID: 13470689
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents.
    Alagarsamy V; Solomon VR; Murugan M
    Bioorg Med Chem; 2007 Jun; 15(12):4009-15. PubMed ID: 17452107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.
    Fonquerna S; Miralpeix M; Pagès L; Puig C; Cardús A; Antón F; Cárdenas A; Vilella D; Aparici M; Calaf E; Prieto J; Gras J; Huerta JM; Warrellow G; Beleta J; Ryder H
    J Med Chem; 2004 Dec; 47(25):6326-37. PubMed ID: 15566302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antihistaminic action of 2,7-diazaphenothiazine and some of its derivatives].
    WERLE E; KOPP E; LEYSATH G
    Arzneimittelforschung; 1962 Apr; 12():443-4. PubMed ID: 14006201
    [No Abstract]   [Full Text] [Related]  

  • 11. 4-Cyclohexyl-1-substituted-4H-[1,2,4]triazolo [4,3-a] quinazolin-5-ones: novel class of H1-antihistaminic agents.
    Alagarsamy V; Meena S; Ramaseshu KV; Solomon VR; Kumar TD
    Chem Biol Drug Des; 2007 Aug; 70(2):158-63. PubMed ID: 17683377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a mathematical topological pattern of antihistaminic activity for the selection of new drug candidates and pharmacology assays.
    Duart MJ; García-Domenech R; Galvez J; Aleman PA; Martín-Algarra RV; Antón-Fos GM
    J Med Chem; 2006 Jun; 49(12):3667-73. PubMed ID: 16759109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiological effects of substances obtained by oxidation of carotene; antihistaminic and antiacetylcholinic effect of retinene].
    BALAKHOVSKII SD; RYVKINA DE; FEDOROVA VN
    Dokl Akad Nauk SSSR; 1953 Dec; 93(5):869-70. PubMed ID: 13127758
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of 4-butyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H(1)-antihistaminic agents.
    Alagarsamy V; Shankar D; Murugesan S
    Biomed Pharmacother; 2008 Mar; 62(3):173-8. PubMed ID: 17936567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of experimental and clinical research with cyproheptadine, a new antihistaminic substance].
    HELM F
    Hautarzt; 1961 Mar; 12():101-5. PubMed ID: 13713190
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical observations with dimetane, a new antihistaminic compound.
    HORSTMAN HA
    Am Pract Dig Treat; 1959 Jan; 10(1):96-7. PubMed ID: 13606327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experimentation with a new antihistaminic: systral].
    ZAFIROPOULO
    Clinique (Paris); 1963 Feb; 57():139-44. PubMed ID: 14003013
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic trial with a new antihistaminic].
    LAPA C
    J Med (Oporto); 1955 Apr; 26(636):828-31. PubMed ID: 14366859
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials with a new antihistaminic with a marked retarding effect].
    SCHECHTMANN CA; BRUJIS R; ROSENZAIN A
    Dia Med; 1961 May; 33():670-2. PubMed ID: 13747341
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experimentation with a new antihistaminic: ilvin].
    FIORE G
    Minerva Med; 1958 Sep; 49(70):3316-9. PubMed ID: 13600135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.